To assess the clinical relevance of our findings, we examined the expression of ALDH1A1 and POU5F1 in a cohort of 462 patients for overall survival (OS) or 420 patients for disease-free survival (DFS), obtained from the Cancer Genome Atlas CRC data set [22]. The gene discussed is POU5F1; the disease is colorectal carcinoma.